Pediatric Dermatology Treatment Market Size & Share, by Drug Class (Anti-Infectives, Corticosteroids, Anti-Acne, Calcineurin Inhibitors, Retinoids); Application (Alopecia, Erythromelalgia, Psoriasis, Atopic Dermatitis); End-user (Hospitals, Clinics, Cosmetic Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3742
  • Published Date: Aug 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Pediatric Dermatology Treatment Market size is expected to register around 9.3% CAGR during the forecast period i.e., between 2024-2036. The growth of the market can be attributed to the increasing prevalence of skin disorders around the world, and rise in awareness levels associated with the progression of dermatology diseases. As per the World Psoriasis Day consortium, as of 2020, 125 million people around the world were suffering from psoriasis, which is about 2 to 3 percent of the total population. Along with these, growing incidences of weakened immune systems among children as a result of sedentary lifestyle is also expected to drive significant growth to the market in the forthcoming years. Furthermore, high healthcare expenditures in developed countries, and surge in technological advancements to develop improved treatment options for skin diseases are projected to offer lucrative opportunities for pediatric dermatology treatment market growth in the near future.


Get more information on this report: Request Free Sample PDF

Pediatric Dermatology Treatment Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing Prevalence of Skin Disorders Worldwide
  • Rising Awareness Levels Associated with the Progression of Dermatology Diseases

Challenges

  • Side Effects of Certain Classes of Treatment Drugs

Pediatric Dermatology Treatment Market: Key Insights

Base Year

2023

Forecast Year

2024–2036

CAGR

9.3%

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Pediatric Dermatology Treatment Segmentation

The market is segmented by application into alopecia, erythromelalgia, psoriasis, atopic dermatitis, and others, out of which, the psoriasis segment is anticipated to hold the largest share in the global pediatric dermatology treatment market. This can be accounted to the increasing occurrence of psoriasis among children across the globe, and growing development of new medications for treating this condition. Additionally, on the basis of end user, the hospitals segment is assessed to acquire the largest share during the forecast period, which can be credited to the high preference of patients to be treated by a healthcare professional in a hospital facility. Apart from this, high number of admissions in hospitals is also predicted to fuel the market segment growth in the future. 

Our in-depth analysis of the global market includes the following segments:

           By Drug Class

  • Anti-Infectives
  • Corticosteroids
  • Anti-Acne
  • Calcineurin Inhibitors
  • Retinoids
  • Others

             By Application

  • Alopecia
  • Erythromelalgia
  • Psoriasis
  • Atopic Dermatitis
  • Others

 

 

           By End User

  • Hospitals
  • Clinics
  • Cosmetic Centers
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Pediatric Dermatology Treatment Industry - Regional Synopsis

On the basis of geographical analysis, the global pediatric dermatology treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in Asia Pacific industry is set to hold largest revenue share by 2036, impelled by large patient pool and growing number of incidences of dermatology diseases among children in the region. Moreover, the market in North America is expected to occupy the largest share during the forecast period ascribing to the high healthcare spending, and increasing awareness about skin diseases in the region. As per the Centers for Medicare & Medicaid Services, the healthcare spending in the United States grew 4.6 percent in 2019, reaching a value of USD 3.8 trillion.  As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent that year. In addition, strong presence of pharmaceutical companies is also anticipated to bolster the pediatric dermatology treatment market growth in the region in the coming years.

Research Nester
Pediatric-Dermatology-Treatment-Market-Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Pediatric Dermatology Treatment Landscape

    • Novartis AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Amgen Inc.
    • AbbVie Inc.
    • Almirall SA
    • Bausch Health Companies Inc.
    • Pfizer Inc.
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Sanofi S.A.
    • Bristol Myers Squibb Company

In the News

  • February 2021- Bristol Myers Squibb announced positive results from POETYK PSO-2, the second Phase III clinical trial evaluating deucravacitinib, which is a novel, selective tyrosine kinase 2 inhibitor for treating patients with moderate to severe plaque psoriasis.

  • May 2020- Sanofi S.A. received the United States Food and Drug Administration for Dupixent for the treatment of moderate-to-severe atopic dermatitis.

Author Credits:  Radhika Pawar


  • Report ID: 3742
  • Published Date: Aug 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Pediatric Dermatology Treatment Market size is expected to register around 9.3% CAGR during the forecast period i.e., between 2024-2036.

The market growth is driven by increasing prevalence of skin disorders worldwide, and rising awareness levels associated with the progression of dermatology diseases.

Asia Pacific industry is set to hold largest revenue share by 2036, impelled by large patient pool and growing number of incidences of dermatology diseases among children in the region.

The major players in the market are Novartis AG, Amgen Inc., AbbVie Inc., Almirall SA, Bausch Health Companies Inc., and others.
Pediatric Dermatology Treatment Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample